BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33843425)

  • 1. Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?
    Coppedè F
    Expert Opin Ther Targets; 2021 Apr; 25(4):283-298. PubMed ID: 33843425
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic regulons in Alzheimer's disease.
    Raval M; Mishra S; Tiwari AK
    Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Epigenetic Targets for Combating Alzheimer's Disease.
    Pandey D; Pal T; Sharma A; Flora S
    Mini Rev Med Chem; 2021; 21(12):1527-1540. PubMed ID: 33371834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.
    Paniri A; Hosseini MM; Akhavan-Niaki H
    Mol Neurobiol; 2024 Mar; 61(3):1282-1317. PubMed ID: 37700216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone Modifications in Alzheimer's Disease.
    Santana DA; Smith MAC; Chen ES
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epigenetics in Alzheimer's disease pathogenesis.
    Stoccoro A; Coppedè F
    Neurodegener Dis Manag; 2018 Jun; 8(3):181-193. PubMed ID: 29888987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.
    Song Y; Zhu XY; Zhang XM; Xiong H
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epigenetic mechanisms of Alzheimer's disease and related drug research].
    Gong HC; Wang YL; Wang HW
    Yao Xue Xue Bao; 2013 Jul; 48(7):1005-13. PubMed ID: 24133967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review.
    Wen KX; Miliç J; El-Khodor B; Dhana K; Nano J; Pulido T; Kraja B; Zaciragic A; Bramer WM; Troup J; Chowdhury R; Ikram MA; Dehghan A; Muka T; Franco OH
    PLoS One; 2016; 11(12):e0167201. PubMed ID: 27973581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: the potential of epigenetic treatments and current clinical candidates.
    Coneys R; Wood IC
    Neurodegener Dis Manag; 2020 Jun; 10(3):543-558. PubMed ID: 32552286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.
    Rao JS; Keleshian VL; Klein S; Rapoport SI
    Transl Psychiatry; 2012 Jul; 2(7):e132. PubMed ID: 22760556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
    Qazi TJ; Quan Z; Mir A; Qing H
    Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer's Disease.
    Maity S; Farrell K; Navabpour S; Narayanan SN; Jarome TJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.
    Klein HU; Bennett DA; De Jager PL
    Acta Neuropathol; 2016 Oct; 132(4):503-14. PubMed ID: 27573688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
    Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
    Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
    Zheng Y; Liu A; Wang ZJ; Cao Q; Wang W; Lin L; Ma K; Zhang F; Wei J; Matas E; Cheng J; Chen GJ; Wang X; Yan Z
    Brain; 2019 Mar; 142(3):787-807. PubMed ID: 30668640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics of Alzheimer's Disease.
    Nikolac Perkovic M; Videtic Paska A; Konjevod M; Kouter K; Svob Strac D; Nedic Erjavec G; Pivac N
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.